SureTrader
Home > Boards > US OTC > Biotechs > CYTODYN INC (CYDY)

Certainly can't dispute the historical batting average, but

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
BlackDoggie Member Profile
 
Followed By 9
Posts 542
Boards Moderated 0
Alias Born 02/17/17
160x600 placeholder
Amended Tender Offer Statement by Issuer (sc To-i/a) Edgar (US Regulatory) - 2/20/2018 4:42:12 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/20/2018 4:39:35 PM
Amended Tender Offer Statement by Issuer (sc To-i/a) Edgar (US Regulatory) - 2/20/2018 6:33:17 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/20/2018 6:33:16 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/16/2018 6:04:59 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/16/2018 6:04:06 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/16/2018 6:02:19 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/16/2018 6:01:53 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/16/2018 6:01:53 PM
Amended Tender Offer Statement by Issuer (sc To-i/a) Edgar (US Regulatory) - 2/14/2018 12:22:03 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/13/2018 4:38:32 PM
Amended Tender Offer Statement by Issuer (sc To-i/a) Edgar (US Regulatory) - 2/7/2018 4:53:35 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/7/2018 4:34:05 PM
Amended Tender Offer Statement by Issuer (sc To-i/a) Edgar (US Regulatory) - 1/31/2018 4:43:36 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 1/31/2018 4:38:23 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/31/2018 4:34:56 PM
Amended Tender Offer Statement by Issuer (sc To-i/a) Edgar (US Regulatory) - 1/25/2018 4:35:52 PM
Amended Tender Offer Statement by Issuer (sc To-i/a) Edgar (US Regulatory) - 1/23/2018 8:14:51 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 1/23/2018 8:03:45 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/23/2018 7:51:29 AM
Amended Tender Offer Statement by Issuer (sc To-i/a) Edgar (US Regulatory) - 1/10/2018 5:01:36 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/10/2018 4:56:01 PM
Amended Tender Offer Statement by Issuer (sc To-i/a) Edgar (US Regulatory) - 1/8/2018 4:37:58 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 1/8/2018 4:36:15 PM
Amended Tender Offer Statement by Issuer (sc To-i/a) Edgar (US Regulatory) - 12/29/2017 5:18:12 PM
BlackDoggie   Thursday, 11/09/17 02:02:41 PM
Re: buckysherm post# 18076
Post # of 20332 
Certainly can't dispute the historical batting average, but it's worth noting that at least one of these milestones (interim data) is nearly completely within the company's control at this point. If they miss that one without explanation, it's on them. Most (all?) previous timeline misses that I can think of involve enrolling patients in trials, which is very much not in the company's complete control. This isn't to excuse past misses - those misses show excessive optimism, lack of foresight or understanding, or some combination thereof. I'm just suggesting a way that at least one of these timelines significantly differs from past timelines, so one may reasonably expect a different result.

As for completing the enrollment of the last ten patients, I'm hopeful that they know something we don't, like that they've maintained a list of patients screened who would now fit the criteria. That could make the timeline accessible, and I would hope that they wouldn't put out such a near-term timeline without some certainty that they could hit it. However, as you've said, their batting average on things not completely in their control is not stellar, so I understand that pessimism.


Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist